Developing personalised therapies for Uveal Melanoma: Understanding disease process and validation of therapeutic targets
Prof Breandán N Kennedy, is a professor of Biomolecular & Biomed Science in the Conway Institute. The goal of his research team is to develop genetic and pharmacological treatments for human blindness.
Uveal melanoma (UV) is a cancer of the eye involving the iris, ciliary body, or choroid (collectively referred to as the uvea). Ireland has a very high incidence of this cancer, with some experts speculating that it is one of the highest incidences worldwide.Back